...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: AACR

I checked with IR. Zenith is attending but not presenting at ASCO. Also, no Zenith presentation at BIO 2019 next month either, according to IR. Seems we're entering a quiet period........

Share
New Message
Please login to post a reply